About: http://data.cimple.eu/news-article/7ee2340668d9931981e6616bd73aa04fa80dc3e9ff2602728c29b3a6     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • European stock markets appeared unmoved Monday by news of fresh Covid vaccine results, as investors mulled glum economic data that could herald another virus-driven downturn. British drugs group AstraZeneca and the University of Oxford said their jointly developed vaccine had shown an average 70-percent effectiveness in trials involving 23,000 people. The results ranged between 62 and 90 percent efficacy depending on the vaccine dosage. The announcement came after other trials of drugs developed by Pfizer/BioNTech and Moderna announced effectiveness above 90 percent. London's benchmark FTSE 100 index nonetheless ended the day with a decline of almost 0.3 percent, while AstraZeneca's share price gave up 3.8 percent to £80. In the eurozone, the markets in Frankfurt and Paris were both almost 0.1 percent lower. "The biggest benefits will be saved for tourism and hospitality," Oanda analyst Craig Erlam forecast. The British pound rebounded however on reports that Brussels and London were set to unveil a long-awaited post-Brexit trade deal. "The results of AstraZeneca and Oxford University's Covid-19 vaccine trial result failed to trigger a major rally in equities with the 70-percent efficacy result perhaps disappointing in comparison to the results from Pfizer and Moderna," said AJ Bell analyst Russ Mould. "In relative terms one can understand why AstraZeneca's result only triggered a shrug of the shoulders from investors." Monday's news came after Pfizer and its German partner BioNTech applied for emergency use authorisation for their drug, which could be rolled out next month. Moderna is expected to make its own application soon. The need for a vaccine has been underscored by soaring infection and death rates in the US and elsewhere as the northern hemisphere heads into winter, when viruses usually spread more. Some US states have started imposing new restrictions, while European countries including England and France have already returned to partial lockdowns. Europe's equity gains were also dented by a closely followed survey that showed economic activity had plunged in November with the fresh restrictions aimed at curbing the second wave of coronavirus -- indicating a quick return to recession. London - FTSE 100: DOWN 0.3 percent at 6,333.84 (close) Frankfurt - DAX 30: DOWN 0.1 percent at 13,126.97 (close) Paris - CAC 40: DOWN 0.1 percent at 5,492.15 (close) EURO STOXX 50: DOWN 0.1 percent at 3,463.04 New York - Dow: UP 0.6 percent at 29,450.67 Hong Kong - Hang Seng: UP 0.1 percent at 26,486.20 (close) Shanghai - Composite: UP 1.1 percent at 3,414.49 (close) Tokyo - Nikkei 225: Closed for a holiday Euro/dollar: DOWN at $1.1835 from $1.1857 at 2200 GMT Pound/dollar: UP at $1.3307 from $1.3275 Dollar/yen: UP at 104.31 yen from 103.86 yen Euro/pound: DOWN at 88.93 pence from 89.32 pence West Texas Intermediate: UP 0.6 percent at $43.00 per barrel Brent North Sea crude: UP 1.0 percent at $45.96 dan-rfj/wai/jj
schema:headline
  • European stock markets 'shrug' at Covid vaccine news
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...tology#hasEmotion
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software